Human Genome Epidemiology Literature Finder
Records 1 - 10 (of 10 Records) |
Query Trace: Breast Neoplasms and MUC16[original query] |
---|
Genomic alterations in breast cancer patients in betel quid and non betel quid chewers. PloS one 2012 7 (8): e43789. Kaushal Mishi, Mishra Ashwani K, Sharma Jagannath, Zomawia Eric, Kataki Amal, Kapur Sujala, Saxena Suni |
Allelic expression imbalance polymorphisms in susceptibility chromosome regions and the risk and survival of breast cancer. Molecular carcinogenesis 2017 01 56 (1): 300-311. Lin Wei, Lin Hong-Da, Guo Xing-Yi, Lin Ying, Su Feng-Xi, Jia Wei-Hua, Tang Lu-Ying, Zheng Wei, Long Ji-Rong, Ren Ze-Fa |
ERBB2 mutation is associated with a worse prognosis in patients with CDH1 altered invasive lobular cancer of the breast. Oncotarget 2016 Nov . Ping Zheng, Siegal Gene P, Harada Shuko, Eltoum Isam-Eldin, Youssef Mariam, Shen Tiansheng, He Jianbo, Huang Yingjie, Chen Dongquan, Li Yiping, Bland Kirby I, Chang Helena R, Shen Dej |
Comprehensive Cohort Analysis of Mutational Spectrum in Early Onset Breast Cancer Patients. Cancers 2020 Jul 12 (8): . Midha Mohit K, Huang Yu-Feng, Yang Hsiao-Hsiang, Fan Tan-Chi, Chang Nai-Chuan, Chen Tzu-Han, Wang Yu-Tai, Kuo Wen-Hung, Chang King-Jen, Shen Chen-Yang, Yu Alice L, Chiu Kuo-Ping, Chen Chien-J |
Somatic mutations in benign breast disease tissues and association with breast cancer risk. BMC medical genomics 2021 7 14 (1): 185. Winham Stacey J, Wang Chen, Heinzen Ethan P, Bhagwate Aditya, Liu Yuanhang, McDonough Samantha J, Stallings-Mann Melody L, Frost Marlene H, Vierkant Robert A, Denison Lori A, Carter Jodi M, Sherman Mark E, Radisky Derek C, Degnim Amy C, Cunningham Julie |
Bioinformatic Analysis of Immune Significance of RYR2 Mutation in Breast Cancer. BioMed research international 2021 12 2021 8072796. Xu Zhiquan, Xiang Ling, Wang Rong, Xiong Yongfu, Zhou He, Gu Haitao, Wang Jijian, Peng Linglo |
Deregulated Immune Pathway Associated with Palbociclib Resistance in Preclinical Breast Cancer Models: Integrative Genomics and Transcriptomics. Genes 2021 1 12 (2): . Pandey Kamal, Lee Eunbyeol, Park Nahee, Hur Jin, Cho Young Bin, Katuwal Nar Bahadur, Kim Seung Ki, Lee Seung Ah, Kim Isaac, An Hee Jung, Hwang Sohyun, Moon Yong W |
Whole-Exome Sequencing Reveals High Mutational Concordance between Primary and Matched Recurrent Triple-Negative Breast Cancers. Genes 2023 9 14 (9): . Jaspreet Kaur, Darshan S Chandrashekar, Zsuzsanna Varga, Bettina Sobottka, Emiel Janssen, Khanjan Gandhi, Jeanne Kowalski, Umay Kiraz, Sooryanarayana Varambally, Ritu Ane |
The mutational landscape of a US Midwestern breast cancer cohort reveals subtype-specific cancer drivers and prognostic markers. Human genomics 2023 7 17 (1): 64. Neetha Nanoth Vellichirammal, Yuan-De Tan, Peng Xiao, James Eudy, Oleg Shats, David Kelly, Michelle Desler, Kenneth Cowan, Chittibabu Gu |
Genomic and transcriptomic analysis of breast cancer identifies novel signatures associated with response to neoadjuvant chemotherapy. Genome medicine 2024 1 16 (1): 11. Gengshen Yin, Liyuan Liu, Ting Yu, Lixiang Yu, Man Feng, Chengjun Zhou, Xiaoying Wang, Guoxin Teng, Zhongbing Ma, Wenzhong Zhou, Chunmiao Ye, Jialin Zhang, Changhua Ji, Linfeng Zhao, Peng Zhou, Yaxun Guo, Xingchen Meng, Qinye Fu, Qiang Zhang, Liang Li, Fei Zhou, Chao Zheng, Yujuan Xiang, Mingming Guo, Yongjiu Wang, Fei Wang, Shuya Huang, Zhigang |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: